Shirley MA - Search Results

1

Oxidative and reductive metabolism of 9-cis-retinoic acid in the rat. Identification of 13,14-dihydro-9-cis-retinoic acid and its taurine conjugate.

Shirley MA, Bennani YL, Boehm MF, Breau AP, Pathirana C, Ulm EH. Shirley MA, et al. Drug Metab Dispos. 1996 Mar;24(3):293-302. Drug Metab Dispos. 1996. PMID: 8820419

2

Effects of retinoid treatment of rats on hepatic microsomal metabolism and cytochromes P450. Correlation between retinoic acid receptor/retinoid x receptor selectivity and effects on metabolic enzymes.

Howell SR, Shirley MA, Ulm EH. Howell SR, et al. Among authors: shirley ma. Drug Metab Dispos. 1998 Mar;26(3):234-9. Drug Metab Dispos. 1998. PMID: 9492386

3

Bexarotene metabolism in rat, dog, and human, synthesis of oxidative metabolites, and in vitro activity at retinoid receptors.

Howell SR, Shirley MA, Grese TA, Neel DA, Wells KE, Ulm EH. Howell SR, et al. Among authors: shirley ma. Drug Metab Dispos. 2001 Jul;29(7):990-8. Drug Metab Dispos. 2001. PMID: 11408365

4

Oxidative metabolism of a rexinoid and rapid phase II metabolite identification by mass spectrometry.

Shirley MA, Wheelan P, Howell SR, Murphy RC. Shirley MA, et al. Drug Metab Dispos. 1997 Oct;25(10):1144-9. Drug Metab Dispos. 1997. PMID: 9321517

5

9-cis retinoic acid induces complete remission but does not reverse clinically acquired retinoid resistance in acute promyelocytic leukemia.

Miller WH Jr, Jakubowski A, Tong WP, Miller VA, Rigas JR, Benedetti F, Gill GM, Truglia JA, Ulm E, Shirley M, et al. Miller WH Jr, et al. Blood. 1995 Jun 1;85(11):3021-7. Blood. 1995. PMID: 7756637 Free article. Clinical Trial.

6

Stereochemical studies on the beta-oxidation of valproic acid in isolated rat hepatocytes.

Shirley MA, Hu P, Baillie TA. Shirley MA, et al. Drug Metab Dispos. 1993 Jul-Aug;21(4):580-6. Drug Metab Dispos. 1993. PMID: 8104116

7

Metabolite interference in pharmacokinetic studies.

Moghaddam MF, Fan JH, Tang Y, Khatsenko O, Katz JC, Shirley MA. Moghaddam MF, et al. Among authors: shirley ma. Drug Metab Lett. 2007 Dec;1(4):272-5. doi: 10.2174/187231207783221475. Drug Metab Lett. 2007. PMID: 19356054

8

Chemoprevention of mammary carcinoma by LGD1069 (Targretin): an RXR-selective ligand.

Gottardis MM, Bischoff ED, Shirley MA, Wagoner MA, Lamph WW, Heyman RA. Gottardis MM, et al. Among authors: shirley ma. Cancer Res. 1996 Dec 15;56(24):5566-70. Cancer Res. 1996. PMID: 8971154

9

Retinoid-induced suppression of squamous cell differentiation in human oral squamous cell carcinoma xenografts (line 1483) in athymic nude mice.

Shalinsky DR, Bischoff ED, Gregory ML, Gottardis MM, Hayes JS, Lamph WW, Heyman RA, Shirley MA, Cooke TA, Davies PJ, et al. Shalinsky DR, et al. Among authors: shirley ma. Cancer Res. 1995 Jul 15;55(14):3183-91. Cancer Res. 1995. PMID: 7541715

10

A HPLC method for the determination of 9-cis retinoic acid (ALRT1057) and its 4-oxo metabolite in human plasma.

Dzerk AM, Carlson A, Loewen GR, Shirley MA, Lee JW. Dzerk AM, et al. Among authors: shirley ma. J Pharm Biomed Anal. 1998 Feb;16(6):1013-9. doi: 10.1016/s0731-7085(97)00114-3. J Pharm Biomed Anal. 1998. PMID: 9547704

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

51 results

Search Page

Filters